A Phase II Study to Assess the Immunogenicity and Safety of DNK-651 in Japanese over 13 years old.
Phase of Trial: Phase II
Latest Information Update: 11 Dec 2018
Price : $35 *
At a glance
- Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Denka Seiken
- 10 Dec 2018 Status changed from recruiting to completed.
- 07 Oct 2017 New trial record